Cabergoline as an Adjunct to Ovulation Induction in Infertile Women with Endometriosis: An Open-label Randomized Study

Endometriosis is a chronic inflammatory disease associated with infertility in upto 50% patients. The standard therapy for these patients is ovulation induction,  which has success rate of around 50%. Cabergoline is antiangiogenic drug used to improve ovulation in women with hyperprolactinoma and PCOS. IT also reduces the level of inflammatory markers in peritoneum. therefore, our proposed approach involves utilizing cabergoline as an adjunct to ovulation induction plus intrauterine insemination cycles for infertility in endometriosis patients. This strategy aims to reduce peritoneal inflammation and progression of endometriosis without adversely affecting ovulation.